Monday, November 18, 2024
- 10:30AM-12:30PM
-
Abstract Number: 2328
Do Patients That Develop PsA Before Psoriasis Have Different Disease Outcomes?
SpA Including PsA – Diagnosis, Manifestations, & Outcomes Poster III- 10:30AM-12:30PM
-
Abstract Number: 2350
Do Smoking and Obesity Impact Secukinumab Treatment Outcomes? Real-world Data from 1,202 European Patients with Psoriatic Arthritis
SpA Including PsA – Treatment Poster III- 10:30AM-12:30PM
-
Abstract Number: 1782
DOCK2 Mutations and Hyper-Inflammatory Syndromes
Pediatric Rheumatology – Basic Science Poster- 10:30AM-12:30PM
-
Abstract Number: 2318
Does the Time Interval Between the Onset of Psoriasis and Psoriatic Arthritis Impact Disease Presentation and Outcomes?
SpA Including PsA – Diagnosis, Manifestations, & Outcomes Poster III- 10:30AM-12:30PM
-
Abstract Number: 2431
DORIS Remission in Patients with SLE Treated with Anifrolumab: Post Hoc Analysis from TULIP-1 and TULIP-2 Trials in Patents with No Reported History of Prior Immunosuppressant Use
SLE – Treatment Poster III- 10:30AM-12:30PM
-
Abstract Number: 2347
Drug Survival in Spondyloarthritis: Anti-IL17 Outperforms Anti-TNF in First Biologic Treatment
SpA Including PsA – Treatment Poster III- 10:30AM-12:30PM
-
Abstract Number: 2046
Duration of Disease and Long-term Outcomes in Patients with Difficult-to-treat Recurrent Pericarditis: A Chronic Condition Treated with NSAIDs, Colchicine, Corticosteroids, and Anti-IL-1 Agents
Miscellaneous Rheumatic & Inflammatory Diseases Poster III- 10:30AM-12:30PM
-
Abstract Number: 2138
DXA-derived 3D Parameters of the Hip Discriminate Prevalent Fragility Fractures in Individuals with Axial Spondyloarthritis
Osteoporosis & Metabolic Bone Disease – Basic & Clinical Science Poster- 10:30AM-12:30PM
-
Abstract Number: 1892
Early Tumor Necrosis Factor Inhibitor Initiation and Chronic Opioid Use in Individuals with Axial Spondyloarthritis
Epidemiology & Public Health Poster III- 10:30AM-12:30PM
-
Abstract Number: 2014
Effect of a Whole Food Plant-Based Diet in Patients with Gout: A Pilot Randomized Controlled Trial
Metabolic & Crystal Arthropathies – Basic & Clinical Science Poster III- 10:30AM-12:30PM
-
Abstract Number: 1885
Effect of Physical Activity on Mortality in Rheumatoid Arthritis: A Dose-Response Analysis
Epidemiology & Public Health Poster III- 10:30AM-12:30PM
-
Abstract Number: 2040
Effective Management of Idiopathic Recurrent Pericarditis with Anakinra in Clinical Practice
Miscellaneous Rheumatic & Inflammatory Diseases Poster III- 10:30AM-12:30PM
-
Abstract Number: 2034
Effectiveness and Tolerability of Tocilizumab in Systemic Autoimmune Rheumatic Disease Associated Intertistial Lung Disease
Miscellaneous Rheumatic & Inflammatory Diseases Poster III- 10:30AM-12:30PM
-
Abstract Number: 2445
Effects of Aminaphtone on TGF-beta1 Serum Concentration as Concomitant Treatment to Standard Therapy in Systemic Sclerosis Patients: A Pilot Study
Systemic Sclerosis & Related Disorders – Clinical Poster III- 10:30AM-12:30PM
-
Abstract Number: 2259
Effects of Anti-Obesity Medications in RA Patients